To Investigate Pharmacokinetics (Absorption, Distribution, Elimination), Safety and Tolerability of a Single Oral Dose of 75 mg Molidustat Tablet in Male and Female Subjects Requiring Hemo- or Peritoneal Dialysis Compared to Healthy Subjects

PHASE1CompletedINTERVENTIONAL

Enrollment

Participants

Timeline

Start Date

January 14, 2015

Primary Completion Date

December 2, 2015

Study Completion Date

June 1, 2016

Conditions

Renal Insufficiency, Chronic

Interventions

DRUG

Molidustat(BAY85-3934)

Two single oral doses of 75 mg molidustat tablet in subjects on hemodialysis and peritoneal dialysis

DRUG

Molidustat(BAY85-3934)

One single oral dose of 75 mg molidustat in healthy subjects

Trial Locations (2)

Kiel

Velbert